Chinese medicine has rich theoretical and practical experience in the treatment of blood stasis and the application of blood-activating and stasis-removing drugs. The widespread use of contemporary blood-activating and blood-stasis treatment methods has made an important contribution to the prevention and treatment of major diseases. However, the clinical application of blood-activating and stasis-transforming Chinese patent medicines still suffers from unclear application indications, efficacy, action characteristics, safety information, dose and course of treatment, etc. Safety issues such as bleeding caused by irrational use of drugs have been a concern in the industry. To provide traditional Chinese medicine practitioners, Western medicine practitioners, general practitioners and clinical pharmacists with general principles for the scientific, rational and standardized use of blood-activating and blood-stasis-removing proprietary Chinese medicines. This guideline writing group follows the evidence-based principles and makes reference to the current high-quality clinical evidence to develop the "Guidelines for Rational Use of Proprietary Chinese Medicines for Promoting Blood circulation and Removing Blood Stasis". The next part contains 18 varieties of blood-activating and stasis-transforming Chinese patent medicines and 26 recommendations, involving mainly cardiovascular and cerebrovascular diseases.

blood stasis syndrome  /  activating blood circulation and removing blood stasis class of proprietary Chinese medicines  /  rational use of drugs  /  guidelines